# Graviti Pharmaceuticals Private Limited – FDA 483, Jul 28, 2026

Source: https://www.keypedia.com/records/483/graviti-pharmaceuticals-private-limited/f17100b6-c419-4332-b1a4-0328f13d7638

> FDA 483 for Graviti Pharmaceuticals Private Limited on July 28, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Graviti Pharmaceuticals Private Limited
- Inspection Date: 2026-07-28
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: Graviti Pharmaceuticals Private Limited, a drug manufacturer in Hyderabad, Telangana, was cited for significant deficiencies during an FDA inspection. Observations included inadequate investigations into foreign object complaints, failure to thoroughly test components for purity and quality prior to use, and insufficient cleaning and maintenance of equipment and utensils, leading to potential contamination risks. These issues indicate a lack of robust quality control and manufacturing practices.

## Related Officers

- [John D. McIntosh](https://www.keypedia.com/people/john-d-mcintosh/063cac5b-0933-4ecf-a9fb-835dd5d25ef2)
- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)

Company: https://www.keypedia.com/companies/graviti-pharmaceuticals-private-limited/767496b4-6b24-44f3-ad5a-7dcf4399b2e2

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8